Advanced Therapies for Retinal Vascular Diseases: Enhancing Durability and Reducing Treatment Burden

home / grand-rounds / advanced-therapies-for-retinal-vascular-diseases-enhancing-durability-and-reducing-treatment

A panel of retina specialists discuss highlights from a recent Ophthalmology Times Grand Rounds event discussing advanced therapies for retinal vascular diseases through patient cases of diabetic macular edema, central retinal vein occlusion, and more.

EP. 1: Case 1: Treatment-Naïve Neovascular Age-Related Macular Degeneration

Lisa J. Faia, MD ;David R. Lally, MD;Scott D. Walter, MD, MSc, FASRS;Sumit Sharma, MD, FASRS

November 15th 2024

In the first case, David Lally, MD presents a patient case of age-related macular degeneration (AMD) highlighting the superior durability of newer treatments.

EP. 2: First Line Treatment Decisions for Age-Related Macular Degeneration

Lisa J. Faia, MD ;David R. Lally, MD;Scott D. Walter, MD, MSc, FASRS;Sumit Sharma, MD, FASRS

November 15th 2024

Sumit Sharma, MD, FASRS asks the panel what they are using for first-line AMD treatment and what considerations factor into decision making, such as insurance coverage or risk of inflammation.

Do Not Sell My Personal Information

Job Board

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777